FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns a monoclonal antibody capable of specifically binding morphine derivatives containing hypervariable heavy chain sections with sequences Seq ID No: 5–7 and light chain hypervariable regions with sequences Seq ID No: 8–10.
EFFECT: invention provides high binding affinity to the morphine derivative and blocking its biological activity.
3 cl, 3 ex, 2 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MONOCLONAL ANTIBODY 6G1 TO MORPHINE DERIVATIVES | 2018 |
|
RU2703494C1 |
| MONOCLONAL ANTI-IDIOTYPIC ANTIBODY AI-K11B, HAVING ANTIGENIC PROPERTIES OF MORPHINE | 2020 |
|
RU2745374C1 |
| MONOCLONAL ANTI-IDIOTYPIC ANTIBODY AI-G1, HAVING ANTIGENIC PROPERTIES OF MORPHINE | 2019 |
|
RU2717989C1 |
| IMMUNOGEN FOR TREATING AND PREVENTING OPIATE ADDICTION | 2013 |
|
RU2548802C1 |
| MONOCLONAL ANTIBODIES TO C-END FRAGMENT OF ANTI-MULLER HORMONE | 2018 |
|
RU2765689C2 |
| MONOCLONAL ANTIBODY SS3-4 TO CONFORMATION HUMAN EPITOPE C3, STRAIN OF HYBRID MOUSE DNA RKKK(P)764D - PRODUCER OF MONOCLONAL ANTIBODY SS3-4 | 2015 |
|
RU2584582C1 |
| ANTIBODIES AGAINST HUMAN STABILIN-1 RECEPTOR | 2023 |
|
RU2823309C1 |
| MONOCLONAL ANTIBODIES AND METHODS OF USING THEM | 2017 |
|
RU2694412C2 |
| MONOCLONAL ANTIBODY TO THE C- TERMINAL FRAGMENT OF ANTI -MULLER HORMONE | 2021 |
|
RU2770003C1 |
| MONOCLONAL ANTIBODY AGAINST THE C-TERMINAL FRAGMENT OF ANTI-MULLERIAN HORMONE | 2021 |
|
RU2764795C1 |
Authors
Dates
2019-10-03—Published
2018-07-23—Filed